5th Edition of Euro-Global Conference on Biotechnology and Bioengineering
September 18-20 | Hybrid Event
AI in Biotechnology
Artificial intelligence (AI) may appear futuristic, but it is already present in a variety of modern technologies. It provides voice and facial recognition capabilities to our handheld devices, for example. AI is also making an impact in biotechnology, where it is now used in many aspects of drug research and discovery. Drug target identification, drug screening, image screening, and predictive modelling are all examples of AI uses in biotech. Artificial intelligence is also being used to sift through scientific papers and manage clinical trial data. Several companies are working on AI technologies for the biotech industry. As traditional approaches like conventional statistical analysis or manual picture scanning reach their practical limits, their services are quickly becoming indispensable. In the field of clinical diagnostics, machine learning has a lot of potential. AI technology for medical applications, for example, are being developed.
Thomas J Webster
Interstellar Therapeutics, United States
Steve Busby
University of Birmingham, United Kingdom
Murray Moo Young
University of Waterloo, Canada
Julia Sidorova
Centro de Investigación Biomédica En Red Enfermedades Hepáticas y Digestivas (CIBEREHD), Spain
Luis Jesus Villarreal Gomez
Universidad Autonoma de Baja California, Mexico
Assad Al Ammar
Specialty Enzymes and Probiotics, United States
Tina Moller Tagmose
Novo Nordisk A/S, DenmarkSubmit your abstract Today
Title : Eliminating implant infection: 30,000 nanotextured implants in humans with no failure
Thomas J Webster, Interstellar Therapeutics, United States
Title : Information leakage: Types, remedies, and open problems
Julia Sidorova, Centro de Investigación Biomédica En Red Enfermedades Hepáticas y Digestivas (CIBEREHD), Spain
Title : Biotech innovations: Bioengineering potential for novel biomanufacturing systems
Murray Moo Young, University of Waterloo, Canada
Title : Development and characterization of exo-ITC: A fibrous bilayer exosome delivery system for dermatological applications
Luis Jesus Villarreal Gomez, Universidad Autonoma de Baja California, Mexico
Title : Targeting noncanonical epitopes in anti-cancer immunotherapy
Michele Mishto, Francis Crick Institute, United Kingdom
Title : Stem cell therapy: An affordable healthcare therapy for various diseases
Anant Marathe, Total Potential Cells (P) Ltd, India